tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Promising Developments in Structure Therapeutics’ Clinical Trials Drive Buy Rating
PremiumRatingsPromising Developments in Structure Therapeutics’ Clinical Trials Drive Buy Rating
17d ago
Structure Therapeutics files automatic mixed securities shelf
Premium
The Fly
Structure Therapeutics files automatic mixed securities shelf
17d ago
Structure Therapeutics initiated with a Buy at Clear Street
Premium
The Fly
Structure Therapeutics initiated with a Buy at Clear Street
24d ago
Structure Therapeutics, Inc.: Promising Pipeline and Strong Financial Position Drive Buy Rating
PremiumRatingsStructure Therapeutics, Inc.: Promising Pipeline and Strong Financial Position Drive Buy Rating
3M ago
Buy Rating for Structure Therapeutics: Promising Phase 2b Results and Strategic Market Positioning
Premium
Ratings
Buy Rating for Structure Therapeutics: Promising Phase 2b Results and Strategic Market Positioning
4M ago
Promising Developments in Weight Management Propel Buy Rating for Structure Therapeutics
Premium
Ratings
Promising Developments in Weight Management Propel Buy Rating for Structure Therapeutics
4M ago
Buy Rating for Structure Therapeutics: Aleniglipron’s Competitive Edge in the Oral GLP-1 Market
PremiumRatingsBuy Rating for Structure Therapeutics: Aleniglipron’s Competitive Edge in the Oral GLP-1 Market
4M ago
Eli Lilly jumps as results from weight-loss pill study rival competitor’s
Premium
The Fly
Eli Lilly jumps as results from weight-loss pill study rival competitor’s
4M ago
JPMorgan says Lilly data ‘highly favorable’ for Structure Therapeutics
Premium
The Fly
JPMorgan says Lilly data ‘highly favorable’ for Structure Therapeutics
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100